Citadel Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $95.1M | Buy |
|
|||||
2024
Q4 | $51.6M | Buy |
|
|||||
2024
Q3 | $43.3M | Buy |
|
|||||
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $7.03M | Sell |
|
|||||
2023
Q4 | $178M | Buy |
|
|||||
2023
Q3 | $109M | Sell |
|
|||||
2023
Q2 | $144M | Sell |
|
|||||
2023
Q1 | $166M | Sell |
|
|||||
2022
Q4 | $298M | Buy |
|
|||||
2022
Q3 | $85.5M | Sell |
|
|||||
2022
Q2 | $107M | Sell |
|
|||||
2022
Q1 | $132M | Sell |
|
|||||
2021
Q4 | $140M | Buy |
|
|||||
2021
Q3 | $5.31M | Buy |
|
|||||
2021
Q2 | $4.85M | Sell |
|
|||||
2021
Q1 | $48.8M | Sell |
|
|||||
2020
Q4 | $60.3M | Buy |
|
|||||
2020
Q3 | $13.3M | Sell |
|
|||||
2020
Q2 | $162M | Buy |
|
|||||
2020
Q1 | $53.2M | Sell |
|
|||||
2019
Q4 | $77.9M | Buy |
|
|||||
2019
Q3 | $8.29M | Sell |
|
|||||
2019
Q2 | $46.5M | Sell |
|
|||||
2019
Q1 | $71.8M | Sell |
|
|||||
2018
Q4 | $80.4M | Sell |
|
|||||
2018
Q3 | $172M | Sell |
|
|||||
2018
Q2 | $270M | Buy |
|
|||||
2018
Q1 | $18M | Buy |
|
|||||
2017
Q4 | $10.1M | Sell |
|
|||||
2017
Q3 | $37.6M | Buy |
|
|||||
2017
Q2 | $22.1M | Sell |
|
|||||
2017
Q1 | $48.4M | Buy |
|
|||||
2016
Q4 | $32.7M | Buy |
|
|||||
2016
Q3 | $25.5M | Buy |
|
|||||
2016
Q2 | $5.38M | Sell |
|
|||||
2016
Q1 | $13.1M | Sell |
|
|||||
2015
Q4 | $68.9M | Buy |
|
|||||
2015
Q3 | $21.7M | Buy |
|
|||||
2015
Q2 | $11.2M | Buy |
|
|||||
2015
Q1 | – | Sell |
|
|||||
2014
Q4 | $139M | Sell |
|
|||||
2014
Q3 | $170M | Buy |
|
|||||
2014
Q2 | $117M | Sell |
|
|||||
2014
Q1 | $161M | Buy |
|
|||||
2013
Q4 | $44.5M | Buy |
|
|||||
2013
Q3 | $27.1M | Buy |
|
|||||
2013
Q2 | $5.74M | Buy |
|